Abstract:The effects of chemotherapy on gastrointestinal cancer are influenced by the chemotherapeutic sensitivity of the cancer cells. Determining the expression of genes related to chemotherapeutic sensitivity has been used as a molecular method. The aim of the study was to clarify the relationships between the expression of genes related to chemotherapeutic sensitivity and the effects of orally active derivatives of fluoropyrimidine on gastric and colorectal cancer. Forty-five patients who underwent adjuvant chemotherapy containing orally active derivatives of fluoropyrimidine after undergoing curative surgery for gastric or colorectal cancer were enrolled. Twenty-four patients had colorectal cancer and 21 patients had gastric cancer. Total RNA was extracted from formalin-fixed, paraffin-embedded specimens of the resected tumors, and the expression of 11 genes was measured using the RT-PCR method. We then analyzed the relationships between the gene expression and the postoperative relapse rate as well as the relationships between clinicopathological factors and postoperative relapse rate. The median observation period of the subjects was 41 months. Twelve out of the 21 gastric cancer patients (57%) and 11 out of the 24 colorectal cancer patients (46%) relapsed. Although the results of a univariate analysis revealed that expression of none of the evaluated genes was related to relapse in the gastric cancer patients, excision repair cross-complementing gene 1 (ERCC1) overexpression was related to the relapse rate in colorectal cancer patients (p=0.023). When 1.295 was set as the cut-off value for ERCC1 overexpression using the receiver operating characteristic (ROC) curve, 67% of patients with ERCC1 overexpression and 25% of patients without ERCC1 overexpression relapsed. The relapse-free survival rate was lower in the group with ERCC1 overexpression than in the group without ERCC1 overexpression (p=0.046). ERCC1 overexpression appears to be a useful predictor of relapse in colorectal cancer patients receiving adjuvant therapy with regimens including orally active derivatives of fluoropyrimidine.

Molecular and Functional Characterization of the SBP-box Transcription Factor SPL-CNR in Tomato Fruit Ripening and Cell Death

Regulation of Fruit Ripening by the Brassinosteroid Biosynthetic Gene SlCYP90B3 Via an Ethylene-Dependent Pathway in Tomato

A SQUAMOSA PROMOTER BINDING PROTEIN, LeSPL-CNR Targeted by SlymiR157 Negatively Regulates Fe Deficiency Response in Tomato Roots

Comparative Physiological and Transcriptomic Analyses Reveal Altered Fe-Deficiency Responses in Tomato Epimutant <i>Colorless Non-ripening</i>

LeSPL-CNR Negatively Regulates Cd Acquisition Through Repressing Nitrate Reductase-Mediated Nitric Oxide Production in Tomato.

The miR157-SPL-CNR module acts upstream of bHLH101 to negatively regulate iron deficiency responses in tomato

Disruption of Gene SPL35, Encoding a Novel CUE Domain-Containing Protein, Leads to Cell Death and Enhanced Disease Response in Rice

SPL33, encoding an eEF1A-like protein, negatively regulates cell death and defense responses in rice.

The Brassinosteroid Signaling Component SlBZR1 Promotes Tomato Fruit Ripening and Carotenoid Accumulation

Tuning LeSPL-CNR Expression by SlymiR157 Affects Tomato Fruit Ripening

Requirement of CHROMOMETHYLASE3 for Somatic Inheritance of the Spontaneous Tomato Epimutation Colourless Non-Ripening

SlCNR Regulates Postharvest Water Loss and Wax Accumulation in Tomato Fruit and Directly Represses the Transcription of Very-Long-chain (VLC) Alkane Biosynthesis-Related Genes SlCER1-2 and SlCER6

Molecular and Genetic Characterization of a Novel Pleiotropic Tomato-Ripening Mutant

A Tomato NAC Transcription Factor, SlNAM1, Positively Regulates Ethylene Biosynthesis and the Onset of Tomato Fruit Ripening

SlERF109-like and SlNAC1 Coordinately Regulated Tomato Ripening by Inhibiting ACO1 Transcription

A tomato NAC transcription factor, SlNAP1, directly regulates gibberellin-dependent fruit ripening

Persulfidation and phosphorylation of transcription factor SlWRKY6 differentially regulate tomato fruit ripening

Gene expression and effects of orally active derivatives of fluoropyrimidine on gastric and colorectal cancer.

Mutagenesis of SlNAC4 by CRISPR/Cas9 Alters Gene Expression and Softening of Ripening Tomato Fruit

SlNAP2 promoted fruit ripening by directly binding the ACS2 promoter and interacting with EIL3

Diversity and Redundancy of the Ripening Regulatory Networks Revealed by the Fruitencode and the New CRISPR/Cas9 CNR and NOR Mutants